State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations

By  

Current Gene Therapy, Vol. 9, Iss. 6, 2009-12 ,pp. : 459-474

Bentham Science Publishers

Access to resources Recommend Favorite

Accounting for susceptibility in risk assessment: The need for full disclosure

By Fowle III J.R.  

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 3, 1997-12 ,pp. : 247-250

Elsevier

Access to resources Recommend Favorite

Accounting for susceptibility in risk assessment: current practice and new directions

By Kimmel C.A.   Neumann D.A.  

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 3, 1997-12 ,pp. : 189-194

Elsevier

Access to resources Recommend Favorite

Nephrotoxic Potential and Toxicokinetics of Tetrabromobisphenol a in Rat for Risk Assessment

By Kang Mi Jeong   Kim Ju Hyun   Shin Sil   Choi Jae Ho   Lee Sang Kyu   Kim Hyung Sik   Kim Nam Deuk   Kang Geon Wook   Jeong Hye Gwang   Kang Wonku   Chun Young Jin   Jeong Tae Cheon  

Journal of Toxicology and Environmental Health, Vol. 72, Iss. 21-22, 2009-01 ,pp. : 1439-1445

Taylor & Francis Ltd

Access to resources Recommend Favorite

Benefit–risk assessment: the use of clinical utility index

By Ouellet Daniele  

Expert Opinion on Drug Safety, Vol. 9, Iss. 2, 2010-03 ,pp. : 289-300

Informa Healthcare

Access to resources Recommend Favorite